APA (7th ed.) Citation

K, C., LY, C., Y, G., Y, Z., T, F., Q, W., . . . A, X. (2026). Author Correction: Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications, 17(1), . https://doi.org/10.1038/s41467-026-71985-w

Chicago Style (17th ed.) Citation

K, Chen, et al. "Author Correction: Adipose-targeted Triiodothyronine Therapy Counteracts Obesity-related Metabolic Complications and Atherosclerosis with Negligible Side Effects." Nature Communications 17, no. 1 (2026). https://doi.org/10.1038/s41467-026-71985-w.

MLA (9th ed.) Citation

K, Chen, et al. "Author Correction: Adipose-targeted Triiodothyronine Therapy Counteracts Obesity-related Metabolic Complications and Atherosclerosis with Negligible Side Effects." Nature Communications, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41467-026-71985-w.